Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.6 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.47.
Market Cap
9.6T
Revenue
4.66T
Profits
186.49B
PE Ratio
51.47
Profit Margin
4.00%
Dividend Yield
0.37%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.11T | -0.67% | 1,665,578 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 658.00B | 1.04% | 5,437,473 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 467.44B | -0.17% | 3,883,803 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 371.70B | -1.24% | 15,032,010 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 357.92B | 2.22% | 4,687,756 | 450.53B |
| 6 | NVS | Novartis AG | 300.52B | -0.53% | 801,261 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 256.25B | 0.44% | 2,780,180 | 61.37B |
| 8 | AMGN | Amgen Inc. | 239.95B | 1.03% | 2,464,347 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 232.47B | -0.08% | 1,729,432 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 206.64B | 0.39% | 9,674,151 | 50.34B |
| 11 | ABT | Abbott Laboratories | 201.88B | 0.03% | 5,917,081 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 181.95B | 0.42% | 6,183,605 | 30.46B |
| 13 | PFE | Pfizer Inc. | 159.42B | -0.36% | 23,845,605 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.22B | -1.71% | 2,510,282 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.79B | -0.08% | 767,492 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 137.43B | 0.40% | 6,812,747 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 131.97B | -1.38% | 1,519,418 | 11.03B |
| 18 | SYK | Stryker Corporation | 125.74B | -0.50% | 1,878,158 | 25.84B |
| 19 | CVS | CVS Health Corporation | 120.36B | 1.17% | 9,231,693 | 412.65B |
| 20 | MDT | Medtronic plc | 118.91B | -0.48% | 6,010,950 | 36.36B |
| 21 | SNY | Sanofi | 109.43B | -0.35% | 1,719,554 | 55.89B |
| 22 | GSK | GSK plc | 103.35B | -1.20% | 2,886,330 | 44.05B |
| 23 | MCK | McKesson Corporation | 101.88B | 1.73% | 600,503 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 92.93B | 0.01% | 1,323,573 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.32B | 0.52% | 805,539 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 82.73B | -0.66% | 672,013 | 15.53B |
| 27 | CI | The Cigna Group | 74.11B | 1.06% | 1,971,810 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.03B | -2.70% | 22,027,881 | 21.00B |
| 29 | ARGX | argenx SE | 63.06B | -2.76% | 318,426 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.78B | 1.80% | 760,395 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.35B | 0.33% | 2,232,970 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 55.45B | -4.30% | 31,587,241 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.04B | 1.25% | 1,400,371 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.16B | 0.79% | 2,722,013 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.96B | -0.66% | 1,310,994 | 22.48B |
| 36 | NTRA | Natera, Inc. | 47.24B | -1.30% | 1,219,524 | 2.71B |
| 37 | HUM | Humana Inc. | 46.42B | 2.04% | 1,455,018 | 145.68B |
| 38 | MDLN | Medline Inc. | 45.62B | 1.28% | 5,826,318 | 29.94B |
| 39 | RVMD | Revolution Medicines, Inc. | 45.35B | 1.01% | 1,598,296 | - |
| 40 | HLN | Haleon plc | 44.44B | 1.60% | 13,657,551 | 14.80B |
| 41 | IDXX | IDEXX Laboratories, Inc. | 44.08B | 0.46% | 388,928 | 4.55B |
| 42 | A | Agilent Technologies, Inc. | 43.33B | -3.50% | 3,950,287 | 7.23B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 43.03B | -1.10% | 3,338,944 | 17.32B |
| 44 | IQV | IQVIA Holdings Inc. | 42.84B | 0.16% | 1,114,139 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 42.29B | -0.66% | 351,539 | 6.13B |
| 46 | VEEV | Veeva Systems Inc. | 40.36B | 0.23% | 1,570,209 | 3.32B |
| 47 | WAT | Waters Corporation | 40.36B | 0.01% | 600,299 | 4.64B |
| 48 | ALC | Alcon Inc. | 35.53B | 0.10% | 1,160,028 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 35.26B | 0.03% | 2,357,874 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 34.36B | -1.39% | 4,451,432 | 4.97B |
| 51 | ILMN | Illumina, Inc. | 33.71B | 1.74% | 2,250,988 | 4.49B |
| 52 | RMD | ResMed Inc. | 33.53B | 0.40% | 1,113,641 | 5.65B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 33.51B | -0.84% | 2,500,802 | 21.27B |
| 54 | CNC | Centene Corporation | 32.43B | 0.97% | 3,491,315 | 180.30B |
| 55 | BIIB | Biogen Inc. | 32.23B | 0.62% | 649,828 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 31.89B | -0.72% | 4,069,410 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.58B | -0.09% | 2,137,241 | 4.80B |
| 58 | BNTX | BioNTech SE | 28.34B | -3.22% | 1,851,011 | 3.03B |
| 59 | MTD | Mettler-Toledo International Inc. | 28.03B | 0.26% | 164,398 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 27.52B | 0.89% | 466,314 | 14.35B |
| 61 | INSM | Insmed Incorporated | 27.07B | -1.42% | 1,341,042 | 1.14B |
| 62 | PHG | Koninklijke Philips N.V. | 26.93B | 0.36% | 566,569 | 20.18B |
| 63 | DGX | Quest Diagnostics Incorporated | 26.92B | -0.21% | 837,736 | 11.56B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.26B | 0.17% | 5,117,294 | 7.53M |
| 65 | INCY | Incyte Corporation | 25.94B | 0.13% | 799,608 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.87B | 0.07% | 473,305 | 3.33B |
| 67 | STE | STERIS plc | 23.19B | -0.03% | 360,996 | 6.04B |
| 68 | THC | Tenet Healthcare Corporation | 22.43B | -0.78% | 752,431 | 21.81B |
| 69 | UTHR | United Therapeutics Corporation | 22.00B | -0.05% | 323,887 | 3.15B |
| 70 | GH | Guardant Health, Inc. | 21.90B | -4.40% | 2,212,301 | 1.18B |
| 71 | GMAB | Genmab A/S | 19.69B | -1.29% | 3,246,508 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.26B | - | 1,499,785 | 8.51B |
| 73 | VTRS | Viatris Inc. | 19.00B | 1.35% | 4,980,492 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.31B | -0.12% | 186,216 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.55B | -0.53% | 329,924 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.52B | 0.07% | 420,086 | 4.60B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.85B | -0.53% | 1,113,409 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.56B | 0.31% | 1,207,968 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.53B | 1.88% | 1,144,766 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.78B | -0.55% | 1,141,188 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.25B | 1.15% | 786,066 | 4.00B |
| 82 | RVTY | Revvity, Inc. | 13.73B | -1.40% | 1,505,425 | 2.91B |
| 83 | BAX | Baxter International Inc. | 13.70B | 0.57% | 4,426,556 | 11.47B |
| 84 | EXEL | Exelixis, Inc. | 13.52B | 0.87% | 2,423,091 | 2.44B |
| 85 | ICLR | ICON Public Limited Company | 13.38B | 0.73% | 420,718 | 8.29B |
| 86 | CORT | Corcept Therapeutics Incorporated | 13.32B | 0.81% | 1,012,862 | 830.81M |
| 87 | PEN | Penumbra, Inc. | 12.75B | -0.44% | 144,268 | 1.50B |
| 88 | BMRN | BioMarin Pharmaceutical Inc. | 12.60B | -2.44% | 2,264,555 | 3.41B |
| 89 | FMS | Fresenius Medical Care AG | 12.46B | 0.43% | 510,822 | 22.19B |
| 90 | SNN | Smith & Nephew plc | 12.42B | 1.23% | 1,051,734 | 6.30B |
| 91 | BTSG | BrightSpring Health Services, Inc. | 12.39B | 1.05% | 2,191,803 | 14.37B |
| 92 | HALO | Halozyme Therapeutics, Inc. | 12.33B | 0.43% | 2,091,282 | 1.66B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.25B | -0.44% | 1,104,529 | 669.50M |
| 94 | ELAN | Elanco Animal Health Incorporated | 12.20B | 1.88% | 3,952,174 | 5.02B |
| 95 | TEM | Tempus AI, Inc. | 11.94B | -8.97% | 11,929,279 | 1.43B |
| 96 | EHC | Encompass Health Corporation | 11.93B | 0.51% | 689,482 | 6.21B |
| 97 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.83B | -0.92% | 145,524 | 1.28B |
| 98 | TECH | Bio-Techne Corporation | 11.35B | 0.21% | 2,001,604 | 1.22B |
| 99 | ALGN | Align Technology, Inc. | 11.34B | -1.79% | 762,048 | 4.14B |
| 100 | GMED | Globus Medical, Inc. | 11.29B | -3.26% | 1,132,312 | 3.14B |
| 101 | DVA | DaVita Inc. | 11.26B | 1.54% | 1,108,972 | 14.01B |
| 102 | GKOS | Glaukos Corporation | 10.95B | 0.41% | 622,292 | 612.84M |
| 103 | AXSM | Axsome Therapeutics, Inc. | 10.76B | -1.14% | 293,225 | 776.57M |
| 104 | CYTK | Cytokinetics, Incorporated | 10.72B | 0.33% | 1,212,286 | 67.67M |
| 105 | ABVX | ABIVAX Société Anonyme | 10.71B | 1.04% | 1,293,321 | 5.67M |
| 106 | UHS | Universal Health Services, Inc. | 10.40B | -0.49% | 567,690 | 18.11B |
| 107 | RDY | Dr. Reddy's Laboratories Limited | 10.39B | 0.33% | 2,069,531 | 3.50B |
| 108 | ENSG | The Ensign Group, Inc. | 10.37B | -0.06% | 260,204 | 5.49B |
| 109 | MOH | Molina Healthcare, Inc. | 10.34B | -0.89% | 556,061 | 42.47B |
| 110 | IONS | Ionis Pharmaceuticals, Inc. | 10.31B | 3.85% | 2,207,101 | 874.09M |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 10.28B | -2.10% | 265,006 | 7.46M |
| 112 | RGEN | Repligen Corporation | 10.25B | 0.27% | 1,497,953 | 785.10M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 10.21B | 0.46% | 300,155 | 2.59B |
| 114 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.03% | 1,148,994 | - |
| 115 | SMMT | Summit Therapeutics Inc. | 10.16B | -3.27% | 4,390,696 | - |
| 116 | KRYS | Krystal Biotech, Inc. | 10.11B | -1.40% | 236,705 | 440.48M |
| 117 | PODD | Insulet Corporation | 10.09B | -1.85% | 1,568,558 | 3.05B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 10.07B | 1.04% | 466,859 | 105.00M |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 10.01B | 0.26% | 483,342 | 281.99M |
| 120 | HSIC | Henry Schein, Inc. | 9.98B | 1.14% | 669,183 | 13.60B |
| 121 | OSCR | Oscar Health, Inc. | 9.81B | -0.72% | 4,682,335 | 15.32B |
| 122 | AVTR | Avantor, Inc. | 9.64B | -1.38% | 5,192,724 | 6.56B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.40B | 0.15% | 640,582 | - |
| 124 | PCVX | Vaxcyte, Inc. | 9.21B | -1.20% | 662,140 | - |
| 125 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.11% | 908,511 | 42.16M |
| 126 | IMVT | Immunovant, Inc. | 8.95B | -2.37% | 1,189,319 | - |
| 127 | TWST | Twist Bioscience Corporation | 8.83B | -3.29% | 1,805,839 | 431.80M |
| 128 | HQY | HealthEquity, Inc. | 8.81B | -0.01% | 512,579 | 1.34B |
| 129 | BRKR | Bruker Corporation | 8.68B | -4.33% | 1,174,232 | 3.50B |
| 130 | QGEN | Qiagen N.V. | 8.64B | -5.20% | 8,620,806 | 2.10B |
| 131 | ATR | AptarGroup, Inc. | 8.57B | -0.04% | 282,302 | 3.93B |
| 132 | TXG | 10x Genomics, Inc. | 8.31B | -2.03% | 3,742,622 | 616.91M |
| 133 | ALKS | Alkermes plc | 8.20B | 1.12% | 1,296,669 | 1.67B |
| 134 | IBRX | ImmunityBio, Inc. | 8.03B | -2.70% | 5,671,527 | 165.79M |
| 135 | TGTX | TG Therapeutics, Inc. | 7.94B | 3.21% | 2,847,159 | 799.54M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.67B | 1.31% | 400,563 | 239.92M |
| 137 | CAI | Caris Life Sciences, Inc. | 7.38B | -0.53% | 5,803,516 | 989.61M |
| 138 | HNGE | Hinge Health, Inc. | 7.26B | 1.76% | 2,583,800 | 720.06M |
| 139 | HIMS | Hims & Hers Health, Inc. | 7.25B | -7.99% | 13,872,556 | 2.58B |
| 140 | SRRK | Scholar Rock Holding Corporation | 7.09B | 3.01% | 1,222,247 | - |
| 141 | CHE | Chemed Corporation | 7.05B | 0.14% | 124,498 | 2.60B |
| 142 | PACS | PACS Group, Inc. | 7.01B | - | 544,987 | 5.55B |
| 143 | GRFS | Grifols, S.A. | 6.94B | -0.12% | 227,286 | 8.48B |
| 144 | CGON | CG Oncology, Inc. | 6.93B | -1.98% | 1,162,619 | 6.23M |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.78B | -5.13% | 992,276 | - |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.58B | 0.83% | 1,046,784 | 1.56B |
| 147 | BLTE | Belite Bio, Inc | 6.40B | -1.36% | 135,336 | - |
| 148 | LQDA | Liquidia Corporation | 6.29B | 2.40% | 1,291,339 | 450.91M |
| 149 | COGT | Cogent Biosciences, Inc. | 6.29B | -1.36% | 1,214,546 | - |
| 150 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | 0.43% | 367,573 | 618.07M |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.19B | 0.44% | 419,052 | 840.85M |
| 152 | BLCO | Bausch + Lomb Corporation | 6.19B | 0.46% | 290,494 | 5.32B |
| 153 | DNTH | Dianthus Therapeutics, Inc. | 6.16B | -0.93% | 531,929 | 1.90M |
| 154 | ERAS | Erasca, Inc. | 6.16B | -0.17% | 2,244,529 | - |
| 155 | TVTX | Travere Therapeutics, Inc. | 6.15B | -0.75% | 1,035,408 | 591.33M |
| 156 | STVN | Stevanato Group S.p.A. | 6.08B | -1.46% | 1,309,699 | 1.40B |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.93B | 1.78% | 897,682 | 1.01B |
| 158 | RDNT | RadNet, Inc. | 5.88B | -2.77% | 549,476 | 2.27B |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.86B | -0.35% | 628,826 | 7.50M |
| 160 | TFX | Teleflex Incorporated | 5.86B | -0.37% | 645,094 | 2.25B |
| 161 | DFTX | Definium Therapeutics, Inc. | 5.81B | -3.65% | 1,727,347 | - |
| 162 | AMRX | Amneal Pharmaceuticals, Inc. | 5.68B | -0.73% | 1,788,138 | 3.12B |
| 163 | MMED | MiniMed Group, Inc. | 5.60B | -2.49% | 910,671 | 3.10B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 5.59B | -2.13% | 158,235 | 290.54M |
| 165 | CRSP | CRISPR Therapeutics AG | 5.52B | -4.08% | 1,119,658 | 13.39M |
| 166 | SHC | Sotera Health Company | 5.47B | -2.04% | 1,992,295 | 1.22B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.39B | -0.55% | 669,641 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.11B | 0.51% | 1,489,610 | 1.14B |
| 169 | HAE | Haemonetics Corporation | 4.93B | -0.37% | 641,055 | 1.35B |
| 170 | WAY | Waystar Holding Corp. | 4.86B | 1.36% | 3,366,699 | 1.21B |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.86B | 1.22% | 1,042,041 | - |
| 172 | DYN | Dyne Therapeutics, Inc. | 4.85B | -0.42% | 1,370,092 | - |
| 173 | PBLS | Parabilis Medicines, Inc. | 4.75B | -2.36% | 340,273 | 148.00K |
| 174 | LFST | LifeStance Health Group, Inc. | 4.65B | -2.49% | 2,722,683 | 1.58B |
| 175 | ICUI | ICU Medical, Inc. | 4.57B | -0.16% | 230,442 | 2.16B |
| 176 | BLLN | BillionToOne, Inc. | 4.56B | 1.80% | 548,565 | 397.41M |
| 177 | DOCS | Doximity, Inc. | 4.51B | -0.12% | 2,869,413 | 655.57M |
| 178 | ELVN | Enliven Therapeutics, Inc. | 4.48B | 2.22% | 1,255,226 | - |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | -0.03% | 581,348 | 2.29B |
| 180 | CELC | Celcuity Inc. | 4.44B | -2.93% | 514,108 | - |
| 181 | NVST | Envista Holdings Corporation | 4.39B | 0.51% | 1,793,811 | 2.86B |
| 182 | HTFL | HeartFlow, Inc. | 4.37B | 0.90% | 2,326,452 | 212.07M |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.33B | 1.65% | 2,639,387 | 10.35M |
| 184 | LIVN | LivaNova PLC | 4.31B | -0.61% | 823,214 | 1.47B |
| 185 | INDV | Indivior Pharmaceuticals, Inc. | 4.27B | -1.87% | 1,840,842 | 1.33B |
| 186 | ITGR | Integer Holdings Corporation | 4.25B | -0.10% | 754,399 | 1.84B |
| 187 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.25B | -1.32% | 3,714,468 | -665.00K |
| 188 | TNGX | Tango Therapeutics, Inc. | 4.13B | 2.64% | 2,088,761 | 53.81M |
| 189 | IRTC | iRhythm Holdings, Inc. | 4.13B | -2.54% | 363,438 | 825.34M |
| 190 | MANE | Veradermics, Incorporated | 4.11B | -4.24% | 717,278 | - |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 4.08B | -1.69% | 1,694,428 | 308.08M |
| 192 | LEGN | Legend Biotech Corporation | 4.06B | -4.03% | 1,930,489 | 1.27B |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.93B | 3.09% | 266,380 | 890.79M |
| 194 | VKTX | Viking Therapeutics, Inc. | 3.88B | -1.95% | 1,748,910 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.87B | -2.89% | 1,321,142 | 3.60M |
| 196 | IDYA | IDEAYA Biosciences, Inc. | 3.86B | 0.93% | 786,771 | 234.13M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.84B | -0.73% | 1,296,259 | 117.00M |
| 198 | IOVA | Iovance Biotherapeutics, Inc. | 3.65B | -2.77% | 15,731,204 | 324.97M |
| 199 | OGN | Organon & Co. | 3.61B | - | 4,583,389 | 6.13B |
| 200 | NHC | National HealthCare Corporation | 3.58B | -2.15% | 90,610 | 1.56B |
| 201 | OPCH | Option Care Health, Inc. | 3.55B | -0.13% | 1,679,108 | 5.69B |
| 202 | PLSE | Pulse Biosciences, Inc. | 3.50B | -2.56% | 345,885 | 1.19M |
| 203 | GPCR | Structure Therapeutics Inc. | 3.49B | -0.16% | 822,246 | - |
| 204 | ABCL | AbCellera Biologics Inc. | 3.44B | -6.27% | 6,591,420 | 66.17M |
| 205 | GRAL | GRAIL, Inc. | 3.42B | -3.72% | 381,019 | 165.26M |
| 206 | VCYT | Veracyte, Inc. | 3.33B | -1.99% | 1,165,434 | 561.90M |
| 207 | QURE | uniQure N.V. | 3.29B | -1.88% | 920,961 | 18.67M |
| 208 | TMDX | TransMedics Group, Inc. | 3.25B | -1.23% | 770,375 | 668.47M |
| 209 | WRBY | Warby Parker Inc. | 3.24B | -4.48% | 2,076,751 | 911.61M |
| 210 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | -3.66% | 1,154,211 | 7.12M |
| 211 | MBX | MBX Biosciences, Inc. | 3.20B | 0.09% | 531,065 | - |
| 212 | TARS | Tarsus Pharmaceuticals, Inc. | 3.20B | 0.15% | 414,069 | 606.33M |
| 213 | CLDX | Celldex Therapeutics, Inc. | 3.19B | 0.47% | 416,890 | 158.00K |
| 214 | IMNM | Immunome, Inc. | 3.18B | -1.79% | 1,355,475 | 4.02M |
| 215 | ARQT | Arcutis Biotherapeutics, Inc. | 3.11B | -1.20% | 1,128,432 | 463.98M |
| 216 | IRON | Disc Medicine, Inc. | 3.11B | 1.42% | 277,237 | - |
| 217 | AVAH | Aveanna Healthcare Holdings Inc. | 2.99B | 4.10% | 5,374,760 | 2.60B |
| 218 | ALMS | Alumis Inc. | 2.98B | -4.72% | 850,804 | 7.40M |
| 219 | BKD | Brookdale Senior Living Inc. | 2.89B | 2.71% | 4,573,169 | 2.93B |
| 220 | SLS | SELLAS Life Sciences Group, Inc. | 2.89B | -7.34% | 8,823,363 | - |
| 221 | ZLAB | Zai Lab Limited | 2.88B | -1.42% | 1,151,368 | 449.61M |
| 222 | BEAM | Beam Therapeutics Inc. | 2.83B | -4.81% | 1,245,306 | 156.04M |
| 223 | ALHC | Alignment Healthcare, Inc. | 2.79B | 2.05% | 3,448,001 | 4.58B |
| 224 | ATAI | AtaiBeckley Inc. | 2.74B | - | 12,309,031 | 4.47M |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.73B | -1.68% | 874,210 | 36.77M |
| 226 | VRDN | Viridian Therapeutics, Inc. | 2.72B | -1.11% | 1,131,115 | 71.13M |
| 227 | PRVA | Privia Health Group, Inc. | 2.68B | -0.47% | 876,614 | 2.36B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.67B | 3.24% | 1,438,726 | 3.37B |
| 229 | AXGN | Axogen, Inc. | 2.65B | -2.32% | 704,123 | 251.17M |
| 230 | SUPN | Supernus Pharmaceuticals, Inc. | 2.62B | -1.61% | 495,506 | 830.44M |
| 231 | RGC | Regencell Bioscience Holdings Limited | 2.62B | -0.19% | 150,448 | - |
| 232 | PHVS | Pharvaris N.V. | 2.62B | 2.87% | 691,824 | - |
| 233 | TRVI | Trevi Therapeutics, Inc. | 2.58B | 0.67% | 1,229,920 | - |
| 234 | PGEN | Precigen, Inc. | 2.57B | -0.42% | 3,350,148 | 85.72M |
| 235 | WGS | GeneDx Holdings Corp. | 2.54B | -2.16% | 504,421 | 454.43M |
| 236 | NEOG | Neogen Corporation | 2.53B | -2.93% | 1,432,915 | 870.40M |
| 237 | RARE | Ultragenyx Pharmaceutical Inc. | 2.53B | -0.43% | 1,536,974 | 717.00M |
| 238 | NKTR | Nektar Therapeutics | 2.52B | -0.45% | 747,947 | 54.59M |
| 239 | ATRC | AtriCure, Inc. | 2.51B | 0.61% | 438,902 | 569.62M |
| 240 | BHC | Bausch Health Companies Inc. | 2.50B | 3.73% | 2,713,109 | 10.85B |
| 241 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.47B | 1.36% | 2,010,324 | 940.61M |
| 242 | PBH | Prestige Consumer Healthcare Inc. | 2.46B | 1.38% | 576,059 | 1.10B |
| 243 | CDNA | CareDx, Inc. | 2.46B | -2.28% | 769,594 | 458.09M |
| 244 | VERA | Vera Therapeutics, Inc. | 2.43B | 4.46% | 2,409,729 | - |
| 245 | GRDN | Guardian Pharmacy Services, Inc. | 2.39B | -0.61% | 349,302 | 1.46B |
| 246 | BFLY | Butterfly Network, Inc. | 2.38B | -6.28% | 4,665,326 | 112.14M |
| 247 | NUVB | Nuvation Bio Inc. | 2.37B | -2.45% | 3,015,227 | 169.90M |
| 248 | OCUL | Ocular Therapeutix, Inc. | 2.37B | -2.71% | 2,358,157 | 52.06M |
| 249 | RAPP | Rapport Therapeutics, Inc. | 2.37B | 2.26% | 365,423 | 20.00M |
| 250 | UFPT | UFP Technologies, Inc. | 2.37B | -1.21% | 108,355 | 631.64M |
| 251 | KOD | Kodiak Sciences Inc. | 2.33B | -2.90% | 717,495 | - |
| 252 | GENB | Generate Biomedicines, Inc. | 2.27B | 9.93% | 2,500,238 | 26.48M |
| 253 | ALMR | Alamar Biosciences, Inc. | 2.27B | -4.50% | 303,719 | 100.42M |
| 254 | URGN | UroGen Pharma Ltd. | 2.26B | -1.49% | 849,685 | 188.73M |
| 255 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | 0.92% | 486,067 | 959.90M |
| 256 | MLYS | Mineralys Therapeutics, Inc. | 2.23B | -1.48% | 591,200 | - |
| 257 | ADUS | Addus HomeCare Corporation | 2.21B | 0.01% | 129,411 | 1.48B |
| 258 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -0.48% | 686,275 | 311.51M |
| 259 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.19B | -2.43% | 6,965,320 | 208.78M |
| 260 | MESO | Mesoblast Limited | 2.19B | -2.12% | 177,705 | 65.38M |
| 261 | CLOV | Clover Health Investments, Corp. | 2.18B | -0.96% | 2,760,666 | 2.48B |
| 262 | COAG | Hemab Therapeutics Holdings, Inc. | 2.18B | -5.07% | 336,959 | - |
| 263 | XRAY | DENTSPLY SIRONA Inc. | 2.17B | -0.27% | 2,904,253 | 3.64B |
| 264 | VCEL | Vericel Corporation | 2.17B | -0.89% | 812,271 | 306.30M |
| 265 | XNCR | Xencor, Inc. | 2.16B | 4.30% | 1,050,750 | 104.97M |
| 266 | ESTA | Establishment Labs Holdings Inc. | 2.15B | -0.84% | 258,924 | 245.82M |
| 267 | TRLV | Trulieve Cannabis Corp. | 2.15B | 0.36% | 1,345,830 | 1.14B |
| 268 | KLRA | Kailera Therapeutics, Inc. | 2.14B | -3.67% | 549,547 | - |
| 269 | ADMA | ADMA Biologics, Inc. | 2.14B | -2.95% | 1,962,843 | 512.28M |
| 270 | HCM | HUTCHMED (China) Limited | 2.11B | -3.56% | 56,358 | 549.12M |
| 271 | MD | Pediatrix Medical Group, Inc. | 2.11B | 0.11% | 681,712 | 1.95B |
| 272 | NEO | NeoGenomics, Inc. | 2.11B | -3.36% | 1,096,237 | 766.30M |
| 273 | PVLA | Palvella Therapeutics, Inc. | 2.10B | 2.61% | 315,523 | - |
| 274 | STOK | Stoke Therapeutics, Inc. | 2.09B | 0.09% | 562,290 | 27.59M |
| 275 | BHVN | Biohaven Ltd. | 2.07B | -1.23% | 1,355,524 | - |
| 276 | ZBIO | Zenas BioPharma, Inc. | 2.06B | -1.98% | 481,882 | 1.00M |
| 277 | ZYME | Zymeworks Inc. | 2.04B | 0.35% | 824,551 | 37.13M |
| 278 | NBTX | Nanobiotix S.A. | 2.02B | -8.93% | 223,895 | 38.27M |
| 279 | PRGO | Perrigo Company plc | 1.98B | 0.14% | 2,105,245 | 4.14B |
| 280 | CMPS | COMPASS Pathways plc | 1.97B | 6.53% | 2,776,364 | - |
| 281 | PGNY | Progyny, Inc. | 1.95B | -0.78% | 815,365 | 1.31B |
| 282 | NVCR | NovoCure Limited | 1.95B | -1.99% | 1,607,227 | 699.19M |
| 283 | ASTH | Astrana Health, Inc. | 1.95B | -3.15% | 371,373 | 3.84B |
| 284 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | -1.36% | 635,735 | 98.34M |
| 285 | TSHA | Taysha Gene Therapies, Inc. | 1.95B | -1.97% | 2,589,727 | 5.49M |
| 286 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.04% | 1,255,680 | - |
| 287 | KARD | Kardigan, Inc. | 1.93B | -1.81% | 281,392 | - |
| 288 | GHRS | GH Research PLC | 1.93B | -0.81% | 162,955 | - |
| 289 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | -3.51% | 1,381,271 | 1.97B |
| 290 | SEPN | Septerna, Inc. | 1.89B | 1.30% | 520,553 | 98.88M |
| 291 | IMCR | Immunocore Holdings plc | 1.89B | -0.73% | 371,184 | 430.78M |
| 292 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.83% | 123,459 | 1.13B |
| 293 | ALVO | Alvotech | 1.87B | 18.51% | 3,178,121 | 494.61M |
| 294 | DMRA | Damora Therapeutics, Inc. | 1.87B | -1.65% | 319,818 | - |
| 295 | SNDA | Sonida Senior Living, Inc. | 1.87B | -0.46% | 326,956 | 481.07M |
| 296 | ETON | Eton Pharmaceuticals, Inc. | 1.84B | 1.51% | 801,541 | 105.60M |
| 297 | LMAT | LeMaitre Vascular, Inc. | 1.83B | -2.32% | 561,997 | 262.43M |
| 298 | PSNL | Personalis, Inc. | 1.82B | -7.18% | 4,793,048 | 69.67M |
| 299 | BLFS | BioLife Solutions, Inc. | 1.82B | 0.24% | 548,520 | 106.69M |
| 300 | SGRY | Surgery Partners, Inc. | 1.81B | -3.93% | 2,148,132 | 3.37B |
| 301 | INSP | Inspire Medical Systems, Inc. | 1.78B | -1.43% | 529,859 | 898.74M |
| 302 | BRVE | Braveheart Bio, Inc. | 1.76B | -0.29% | 101,994 | - |
| 303 | NTLA | Intellia Therapeutics, Inc. | 1.76B | -2.18% | 3,117,690 | 59.51M |
| 304 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -0.41% | 1,443,931 | 252.25M |
| 305 | RXRX | Recursion Pharmaceuticals, Inc. | 1.74B | -7.14% | 15,155,115 | 54.86M |
| 306 | FTRE | Fortrea Holdings Inc. | 1.74B | -0.44% | 1,053,469 | 2.68B |
| 307 | ANAB | AnaptysBio, Inc. | 1.73B | 1.21% | 627,045 | 232.39M |
| 308 | VIR | Vir Biotechnology, Inc. | 1.68B | 1.33% | 1,739,718 | 303.23M |
| 309 | AVLN | Avalyn Pharma Inc. | 1.67B | -1.77% | 158,377 | - |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.64B | 0.58% | 282,286 | 20.00M |
| 311 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | 0.46% | 870,743 | 335.41M |
| 312 | ANIP | ANI Pharmaceuticals, Inc. | 1.59B | -1.57% | 327,756 | 978.38M |
| 313 | ARDT | Ardent Health, Inc. | 1.59B | 2.37% | 420,273 | 6.41B |
| 314 | OMCL | Omnicell, Inc. | 1.58B | -2.59% | 512,007 | 1.25B |
| 315 | KMTS | Kestra Medical Technologies, Ltd. | 1.58B | -0.30% | 171,362 | 95.13M |
| 316 | AGL | agilon health, inc. | 1.57B | -2.89% | 216,022 | 5.92B |
| 317 | HCSG | Healthcare Services Group, Inc. | 1.56B | 0.13% | 559,095 | 1.86B |
| 318 | AAPG | Ascentage Pharma Group International | 1.56B | -1.71% | 6,540 | 94.61M |
| 319 | BCAX | Bicara Therapeutics Inc. | 1.56B | -1.34% | 669,732 | - |
| 320 | TYRA | Tyra Biosciences, Inc. | 1.56B | 0.15% | 321,121 | - |
| 321 | LBRX | LB Pharmaceuticals Inc | 1.56B | 1.24% | 252,690 | - |
| 322 | TRAX | First Tracks Biotherapeutics, Inc. | 1.55B | 0.39% | 677,251 | - |
| 323 | TNDM | Tandem Diabetes Care, Inc. | 1.55B | -0.45% | 1,064,351 | 1.04B |
| 324 | SLBT | SL Science Holding Limited | 1.55B | 2.26% | 42,680 | 3.27M |
| 325 | INBX | Inhibrx Biosciences, Inc. | 1.54B | 1.26% | 373,620 | 1.30M |
| 326 | CNMD | CONMED Corporation | 1.54B | 0.82% | 340,035 | 1.37B |
| 327 | INVA | Innoviva, Inc. | 1.52B | -0.19% | 510,304 | 440.00M |
| 328 | ABSI | Absci Corporation | 1.52B | -7.43% | 2,203,548 | 1.56M |
| 329 | INNV | InnovAge Holding Corp. | 1.50B | 0.55% | 195,310 | 949.17M |
| 330 | HROW | Harrow, Inc. | 1.49B | -2.81% | 419,014 | 275.59M |
| 331 | FRNM | Freenome, Inc. | 1.48B | -0.22% | 426,168 | 35.41M |
| 332 | OMDA | Omada Health, Inc. | 1.47B | 0.80% | 942,471 | 309.76M |
| 333 | NVAX | Novavax, Inc. | 1.46B | -0.89% | 5,579,177 | 413.80M |
| 334 | ENOV | Enovis Corporation | 1.45B | -3.26% | 625,290 | 2.30B |
| 335 | AKTS | Aktis Oncology, Inc. | 1.44B | 7.94% | 774,581 | 10.06M |
| 336 | AZTA | Azenta, Inc. | 1.44B | -12.09% | 1,895,730 | 613.81M |
| 337 | PAHC | Phibro Animal Health Corporation | 1.43B | -2.78% | 153,192 | 1.50B |
| 338 | ATEC | Alphatec Holdings, Inc. | 1.43B | -2.53% | 1,717,744 | 815.05M |
| 339 | MGTX | MeiraGTx Holdings plc | 1.42B | 3.42% | 821,374 | 397.50M |
| 340 | ANRO | Alto Neuroscience, Inc. | 1.42B | 5.75% | 867,970 | - |
| 341 | APMD | Apnimed, Inc. | 1.42B | -8.56% | 244,556 | 120.15M |
| 342 | SVRA | Savara Inc. | 1.41B | -0.54% | 1,323,851 | - |
| 343 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | 0.65% | 617,367 | - |
| 344 | SDGR | Schrödinger, Inc. | 1.40B | -4.77% | 914,550 | 259.04M |
| 345 | OMER | Omeros Corporation | 1.40B | 0.26% | 1,425,780 | 38.42M |
| 346 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | -5.21% | 1,110,089 | - |
| 347 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.95% | 225,595 | - |
| 348 | LTGO | Latigo Biotherapeutics, Inc. | 1.39B | -1.65% | 234,073 | - |
| 349 | REPL | Replimune Group, Inc. | 1.39B | -0.41% | 2,081,185 | - |
| 350 | PNTG | The Pennant Group, Inc. | 1.36B | 0.03% | 226,918 | 1.10B |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.36B | -1.47% | 483,895 | - |
| 352 | JBIO | Jade Biosciences, Inc. | 1.36B | -0.05% | 595,723 | - |
| 353 | VOR | Vor Biopharma Inc. | 1.34B | -2.78% | 500,004 | - |
| 354 | AMN | AMN Healthcare Services, Inc. | 1.34B | 0.15% | 384,764 | 3.43B |
| 355 | AORT | Artivion, Inc. | 1.31B | -4.24% | 1,036,010 | 471.47M |
| 356 | MNKD | MannKind Corporation | 1.31B | -1.93% | 2,812,486 | 393.63M |
| 357 | MLTX | MoonLake Immunotherapeutics | 1.31B | -2.47% | 1,138,087 | - |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.30B | -0.30% | 654,659 | 1.65B |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -0.95% | 110,488 | - |
| 360 | NUTX | Nutex Health Inc. | 1.28B | 0.95% | 167,070 | 846.72M |
| 361 | CRON | Cronos Group Inc. | 1.26B | 3.02% | 2,216,784 | 179.09M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | -1.98% | 756,581 | 337.34M |
| 363 | CERT | Certara, Inc. | 1.21B | -5.58% | 2,304,642 | 421.75M |
| 364 | ODTX | Odyssey Therapeutics, Inc. | 1.21B | -4.70% | 257,413 | 99.00K |
| 365 | IMTX | Immatics N.V. | 1.19B | -2.69% | 338,149 | 47.65M |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -2.56% | 513,477 | - |
| 367 | BVS | Bioventus Inc. | 1.18B | -2.50% | 669,501 | 581.85M |
| 368 | GLUE | Monte Rosa Therapeutics, Inc. | 1.18B | -3.67% | 1,999,001 | 28.73M |
| 369 | GDRX | GoodRx Holdings, Inc. | 1.17B | -0.29% | 1,120,420 | 785.23M |
| 370 | STAA | STAAR Surgical Company | 1.17B | 0.52% | 562,081 | 339.59M |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.15B | -1.06% | 171,047 | 804.27M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.14B | -4.59% | 214,076 | 1.04B |
| 373 | JANX | Janux Therapeutics, Inc. | 1.14B | 6.96% | 1,452,370 | 24.00M |
| 374 | SANA | Sana Biotechnology, Inc. | 1.13B | -3.32% | 1,924,902 | - |
| 375 | TDOC | Teladoc Health, Inc. | 1.13B | -2.97% | 3,176,318 | 2.49B |
| 376 | IRMD | IRADIMED CORPORATION | 1.11B | -0.76% | 82,523 | 86.34M |
| 377 | OPK | OPKO Health, Inc. | 1.10B | - | 1,919,928 | 587.90M |
| 378 | KURA | Kura Oncology, Inc. | 1.10B | 4.29% | 2,696,322 | 77.23M |
| 379 | IVA | Inventiva S.A. | 1.09B | 0.43% | 648,644 | 7.94M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.03B | -2.82% | 759,039 | 59.00K |
| 381 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.87% | 1,675,637 | 41.47M |
| 382 | GMRS | GMR Solutions Inc. | 1.03B | -1.78% | 675,398 | 5.88B |
| 383 | ABUS | Arbutus Biopharma Corporation | 1.03B | -0.19% | 18,141,086 | 181.72M |
| 384 | CSTL | Castle Biosciences, Inc. | 1.02B | -2.13% | 357,667 | 357.28M |
| 385 | WVE | Wave Life Sciences, Inc. | 1.01B | -3.21% | 4,555,259 | 65.37M |
| 386 | QDEL | QuidelOrtho Corporation | 993.66M | -1.70% | 1,039,094 | 2.67B |
| 387 | PCRX | Pacira BioSciences, Inc. | 990.97M | 0.77% | 336,672 | 746.16M |
| 388 | CADL | Candel Therapeutics, Inc. | 984.03M | -2.06% | 959,089 | - |
| 389 | SLDB | Solid Biosciences Inc. | 982.18M | -1.51% | 1,114,778 | - |
| 390 | GERN | Geron Corporation | 976.56M | - | 13,109,416 | 204.56M |
| 391 | IMMX | Immix Biopharma, Inc. | 973.65M | -0.37% | 1,416,100 | - |
| 392 | ANNX | Annexon, Inc. | 959.27M | -0.20% | 3,378,233 | - |
| 393 | DSGN | Design Therapeutics, Inc. | 953.12M | 1.60% | 408,655 | - |
| 394 | HELP | Cybin Inc. | 951.24M | 3.42% | 1,864,146 | - |
| 395 | CLYM | Climb Bio, Inc. | 941.95M | -5.09% | 1,177,960 | - |
| 396 | ARDX | Ardelyx, Inc. | 931.96M | -3.86% | 5,216,758 | 450.89M |
| 397 | GLAS | Glass House Brands Inc. | 931.12M | 0.92% | 278,352 | 176.98M |
| 398 | ACRS | Aclaris Therapeutics, Inc. | 928.83M | -1.56% | 1,272,817 | 8.22M |
| 399 | CBLL | CeriBell, Inc. | 918.77M | -1.07% | 408,939 | 101.96M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 915.42M | -0.37% | 210,264 | 730.02M |
| 401 | OLMA | Olema Pharmaceuticals, Inc. | 912.60M | -2.43% | 727,325 | - |
| 402 | ANL | Adlai Nortye Ltd. | 911.87M | 3.36% | 185,762 | 18.06M |
| 403 | FTH | Faeth Therapeutics, Inc. | 896.92M | 8.47% | 448,468 | - |
| 404 | COLL | Collegium Pharmaceutical, Inc. | 890.40M | 0.89% | 758,446 | 808.21M |
| 405 | BBNX | Beta Bionics, Inc. | 887.65M | 3.57% | 864,534 | 119.01M |
| 406 | ATTO | Attovia Therapeutics, Inc. | 887.26M | -0.87% | 81,037 | 1.35M |
| 407 | TBPH | Theravance Biopharma, Inc. | 883.14M | - | 407,285 | 104.31M |
| 408 | SGP | SpyGlass Pharma, Inc. | 878.34M | -0.94% | 70,133 | - |
| 409 | SIBN | SI-BONE, Inc. | 872.62M | -2.45% | 699,828 | 213.60M |
| 410 | INMD | InMode Ltd. | 867.96M | 0.27% | 425,023 | 374.63M |
| 411 | AVR | Anteris Technologies Global Corp. | 857.63M | -2.00% | 802,511 | 2.24M |
| 412 | FDMT | 4D Molecular Therapeutics, Inc. | 850.21M | -2.78% | 1,474,744 | 92.01M |
| 413 | RIGL | Rigel Pharmaceuticals, Inc. | 842.65M | -1.70% | 542,006 | 276.79M |
| 414 | DBVT | DBV Technologies S.A. | 841.82M | -2.82% | 122,736 | 5.04M |
| 415 | HSTM | HealthStream, Inc. | 841.53M | -0.31% | 200,077 | 321.12M |
| 416 | AURA | Aura Biosciences, Inc. | 819.27M | 1.28% | 843,826 | - |
| 417 | ACHV | Achieve Life Sciences, Inc. | 817.05M | -0.63% | 920,742 | - |
| 418 | PHAR | Pharming Group N.V. | 814.98M | -3.29% | 23,169 | 366.48M |
| 419 | OCS | Oculis Holding AG | 813.63M | 0.69% | 150,388 | 1.45M |
| 420 | OBX | Obsidian Therapeutics, Inc. | 810.20M | -6.03% | 133,103 | - |
| 421 | AHG | Akso Health Group | 807.91M | 1.44% | 3,722 | 13.83M |
| 422 | SLN | Silence Therapeutics plc | 800.18M | 0.15% | 723,687 | 615.00K |
| 423 | NGNE | Neurogene Inc. | 793.25M | 2.61% | 439,100 | 925.00K |
| 424 | STTK | Shattuck Labs, Inc. | 792.87M | 4.91% | 2,055,161 | 1.00M |
| 425 | VREX | Varex Imaging Corporation | 780.58M | 0.05% | 635,156 | 865.00M |
| 426 | NVCT | Nuvectis Pharma, Inc. | 777.72M | 1.32% | 231,128 | - |
| 427 | DRUG | Bright Minds Biosciences Inc. | 768.91M | -0.51% | 107,839 | - |
| 428 | AHCO | AdaptHealth Corp. | 751.09M | - | 1,743,531 | 3.36B |
| 429 | MNPR | Monopar Therapeutics Inc. | 747.47M | 3.38% | 239,188 | - |
| 430 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 732.79M | 0.66% | 338,519 | - |
| 431 | CBIO | Crescent Biopharma, Inc. | 726.33M | -1.05% | 131,536 | 11.88M |
| 432 | PHR | Phreesia, Inc. | 722.58M | -3.55% | 626,521 | 495.59M |
| 433 | SOPH | SOPHiA GENETICS SA | 719.33M | -2.31% | 655,647 | 86.17M |
| 434 | ASMB | Assembly Biosciences, Inc. | 718.32M | 2.62% | 384,171 | 74.85M |
| 435 | CTMX | CytomX Therapeutics, Inc. | 716.89M | 0.30% | 3,191,675 | 18.30M |
| 436 | TECX | Tectonic Therapeutic, Inc. | 712.97M | -3.08% | 222,281 | - |
| 437 | SCTX | Scribe Therapeutics Inc. | 702.70M | 9.14% | 545,548 | 36.28M |
| 438 | SSII | SS Innovations International, Inc. | 701.35M | -2.37% | 50,013 | 52.40M |
| 439 | ALLO | Allogene Therapeutics, Inc. | 701.35M | -2.87% | 4,755,951 | 4.64M |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 691.82M | -1.85% | 784,475 | 136.07M |
| 441 | PHAT | Phathom Pharmaceuticals, Inc. | 687.86M | -2.37% | 992,807 | 239.66M |
| 442 | OABI | OmniAb, Inc. | 684.79M | 8.78% | 1,941,317 | 38.46M |
| 443 | GYRE | Gyre Therapeutics, Inc. | 682.86M | -6.80% | 53,276 | 109.82M |
| 444 | IRWD | Ironwood Pharmaceuticals, Inc. | 682.44M | -3.73% | 1,384,233 | 389.32M |
| 445 | EVO | Evotec SE | 679.06M | -2.07% | 22,647 | 819.47M |
| 446 | PRLD | Prelude Therapeutics Incorporated | 666.38M | -2.41% | 515,716 | 22.42M |
| 447 | KIDS | OrthoPediatrics Corp. | 654.57M | -2.26% | 324,512 | 252.72M |
| 448 | ANGO | AngioDynamics, Inc. | 651.81M | 0.13% | 179,114 | 320.17M |
| 449 | CRMD | CorMedix Inc. | 645.38M | 0.98% | 1,012,332 | 462.25M |
| 450 | TLRY | Tilray Brands, Inc. | 640.10M | -2.48% | 3,096,815 | 915.45M |
| 451 | VALN | Valneva SE | 635.77M | -3.02% | 22,211 | 163.30M |
| 452 | SGMT | Sagimet Biosciences Inc. | 634.64M | -0.39% | 1,242,184 | - |
| 453 | AGMB | AgomAb Therapeutics NV | 631.36M | -3.25% | 31,652 | - |
| 454 | MPLT | MapLight Therapeutics, Inc. | 631.34M | 1.34% | 563,455 | - |
| 455 | CTNM | Contineum Therapeutics, Inc. | 625.64M | -3.26% | 261,079 | - |
| 456 | STLN | Starling Oncology, Inc. | 624.75M | -5.26% | 1,228,998 | 587.24M |
| 457 | AUTL | Autolus Therapeutics plc | 622.82M | -2.90% | 1,222,527 | 117.39M |
| 458 | MDXG | MiMedx Group, Inc. | 622.40M | -1.39% | 846,657 | 355.17M |
| 459 | VSTM | Verastem, Inc. | 621.27M | -0.44% | 1,166,472 | 87.53M |
| 460 | CTEV | Claritev Corporation | 619.94M | -1.85% | 76,191 | 994.67M |
| 461 | ARVN | Arvinas, Inc. | 610.71M | -0.32% | 500,358 | 316.70M |
| 462 | ALT | Altimmune, Inc. | 604.95M | - | 2,724,599 | 31.00K |
| 463 | EIKN | Eikon Therapeutics, Inc. | 604.48M | -2.02% | 398,364 | - |
| 464 | ZURA | Zura Bio Limited | 603.72M | 7.69% | 8,341,828 | - |
| 465 | AQST | Aquestive Therapeutics, Inc. | 602.46M | 3.00% | 2,610,398 | 54.09M |
| 466 | ENTX | Entera Bio Ltd. | 592.15M | 5.88% | 258,132 | 42.00K |
| 467 | WEAV | Weave Communications, Inc. | 583.19M | - | 3,416,538 | 257.79M |
| 468 | DCTH | Delcath Systems, Inc. | 581.20M | -2.28% | 417,052 | 95.42M |
| 469 | EOLS | Evolus, Inc. | 579.92M | 4.65% | 1,320,319 | 316.49M |
| 470 | PRME | Prime Medicine, Inc. | 578.19M | -4.13% | 2,267,580 | 4.07M |
| 471 | CTKB | Cytek Biosciences, Inc. | 577.13M | -7.69% | 943,485 | 206.71M |
| 472 | BWAY | BrainsWay Ltd. | 572.43M | -3.73% | 97,712 | 60.70M |
| 473 | ARTV | Artiva Biotherapeutics, Inc. | 563.21M | 5.40% | 307,236 | 251.00K |
| 474 | OVID | Ovid Therapeutics Inc. | 550.74M | 0.71% | 1,230,371 | 1.58M |
| 475 | CERS | Cerus Corporation | 542.10M | -4.27% | 1,623,599 | 221.55M |
| 476 | FLGT | Fulgent Genetics, Inc. | 535.17M | -2.26% | 259,917 | 323.93M |
| 477 | EVH | Evolent Health, Inc. | 533.64M | -0.42% | 2,055,918 | 2.10B |
| 478 | SPRY | ARS Pharmaceuticals, Inc. | 532.04M | -2.90% | 1,936,733 | 116.93M |
| 479 | RGNX | REGENXBIO Inc. | 531.74M | -24.86% | 5,446,548 | 174.48M |
| 480 | TCMD | Tactile Systems Technology, Inc. | 529.16M | -1.93% | 286,492 | 350.31M |
| 481 | SRTA | Strata Critical Medical, Inc. | 528.15M | -4.33% | 887,530 | 255.98M |
| 482 | CABA | Cabaletta Bio, Inc. | 525.59M | -0.96% | 3,107,920 | - |
| 483 | RZLT | Rezolute, Inc. | 523.38M | -1.57% | 1,297,416 | - |
| 484 | KYTX | Kyverna Therapeutics, Inc. | 509.59M | -2.14% | 566,148 | - |
| 485 | CCCC | C4 Therapeutics, Inc. | 504.40M | 2.50% | 1,753,266 | 35.04M |
| 486 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 487 | EVMN | Evommune, Inc. | 496.11M | -2.50% | 228,580 | 10.00M |
| 488 | SENS | Senseonics Holdings, Inc. | 495.96M | -3.40% | 856,463 | 48.55M |
| 489 | BLSM | BlossomHill Therapeutics, Inc. | 491.22M | -2.14% | 155,962 | - |
| 490 | KMDA | Kamada Ltd. | 490.54M | 2.31% | 198,829 | 191.85M |
| 491 | RLMD | Relmada Therapeutics, Inc. | 488.55M | -1.08% | 935,748 | - |
| 492 | QTTB | Q32 Bio Inc. | 487.03M | 2.44% | 691,058 | 53.74M |
| 493 | PROK | ProKidney Corp. | 486.74M | - | 980,540 | 818.00K |
| 494 | NRC | NRC Health | 484.86M | -1.22% | 72,704 | 140.00M |
| 495 | PRTA | Prothena Corporation plc | 482.05M | -0.63% | 248,124 | 54.53M |
| 496 | NPCE | NeuroPace, Inc. | 480.20M | -0.29% | 117,661 | 106.99M |
| 497 | EPRX | Eupraxia Pharmaceuticals Inc. | 478.87M | 8.17% | 1,355,731 | - |
| 498 | PBYI | Puma Biotechnology, Inc. | 470.78M | -1.30% | 266,137 | 231.24M |
| 499 | CLPT | ClearPoint Neuro, Inc. | 462.75M | -1.43% | 422,072 | 42.28M |
| 500 | SI | Shoulder Innovations, Inc. | 462.60M | 0.73% | 75,053 | 60.06M |